Series A - AusperBio
Investment Firm
Overview
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Announced Date
Jul 14, 2024
Closed on Date
Jul 14, 2024
Funding Type
Series A
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 BioVenture |
Round Details and Background
AusperBio raised $37000000 on 2024-07-14 in Series A
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 01, 2023 |  Seed Round - AusperBio | - | 13.7M | |
| Jul 14, 2024 | Series A - AusperBio | 5 | - | 37.0M |
Recent Activity
There is no recent news or activity for this profile.